glp 1 pseudotumor cerebri Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals IIH (Idiopathic Intracranial Hypertension): Symptoms,

The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity

Boesen Law files locally first to ensure deadlines and statutes of limitations are met before the transfer

Capacity of Mentha spicata (spearmint) extracts in alleviating hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome rat model

All packs are air tight sealed and expire up to 09.2029

with no cause identified) (Punab et al

Contraindication Semaglutide is contraindicated in pregnancy